|
Fellows 2007
Recent and Current Hematology/Oncology Fellows
FELLOW NAME: Alka Srivastava, MD
Year: 1998 - 2001
Internal Medicine Residency: State University of New York Health Science Center of Brooklyn, NY
Board certification: Internal Medicine; Hematology; Medical Oncology
Current position: Attending, Winter Cancer Center, Ogdensburg, NY
Practice or research interests: Community Clinical Practice of Hematology/Oncology
FELLOW NAME: Margaret Kennedy, MD, MSc
Year: 1999 - 2002
Internal Medicine Residency: St. Luke's - Roosevelt Hospital Center, NY
Board certification: Internal Medicine; Hematology; Medical Oncology
Current position: Associate Director of Hemostasis Thrombosis Laboratory, Western Pennsylvania Cancer Institute, Director of Therapeutic Apheresis, Western Pennsylvania Hospital, West Penn Allegheny Health System, PA
Practice or research interests: Coagulation and general hematology
FELLOW NAME: Zafer Yildirim, MD, PhD
Year: 2000 - 2003
Internal Medicine Residency: Michigan State University College of Human Medicine/Spectrum Health
Board certification: Internal Medicine; Hematology; Medical Oncology
Current position: Attending, St. John Medical Center, Longview, WA
Practice or research interests: Tumor immunology and critical care
FELLOW NAME: Chris Holmes, MD, PhD
Year: 2001 – 2004
Internal Medicine Residency: University of Vermont/Fletcher Allen Health Care, VT
Chief Medical Resident: University of Vermont/Fletcher Allen Health Care, VT
Board certification: Internal Medicine; Hematology; Medical Oncology
Current position: Assistant Professor of Medicine and Attending Physician, Hematology-Oncology Unit, University of Vermont College of Medicine/Fletcher Allen Health Care, VT
Practice or research interests: Platelet biology; coagulation and cancer; Hematology
FELLOW NAME: Aqeel Gillani, MBBS
Year: 2001 – 2004
Internal Medicine Residency: Michigan State University, Kalamazoo, MI
Board certifications: Internal Medicine; Hematology; Medical Oncology
Current position: Attending Physician, C.R Wood Cancer Center, Glens Falls, NY
Practice or research interests: Hematology & Medical Oncology; Lung cancer
FELLOW NAME: William Eric Spielvogle, MD
Year: 2001 – 2004
Internal Medicine Residency: Mercy Hospital of Pittsburgh
Board certifications: Internal Medicine; Hematology; Medical Oncology
Current position: Attending, UPMC Horizon, and Jameson Hospital, PA
Practice or research interests: Breast Cancer, Cancer genetics, General Hematology/Oncology
FELLOW NAME: Matthew Duggan, DO
Year: 2002 – 2005
Internal Medicine Residency: Maine Medical Center, Portland, ME
Board certifications: Internal Medicine; Hematology; Medical Oncology
Current position: Maine Center for Cancer Medicine, Portland, ME
Practice or research interests: Hematology & Medical Oncology; Supportive care; anti-emetic clinical trials
FELLOW NAME: Jonathan Eneman, MD
Year: 2002 – 2005
Internal Medicine Residency: Beth Israel Deaconess Medical Center, Boston, MA
Board certifications: Internal Medicine; Hematology; Medical Oncology
Current position: York Hospital, York, ME
Practice or research interests: Hematology & Medical Oncology; Community cancer center administration; Cancer and end stage renal disease
FELLOW NAME: Musaberk Goksel, MD
Year: 2003 – 2006
Internal Medicine Residency: Mercy Hospital and Medical Center, Chicago, IL
Board certifications: Internal Medicine; Hematology; Medical Oncology
Current position: Kosciusko Community Hospital Cancer Center, Warsaw, IN
Practice or research interests: Hematology & Medical Oncology
FELLOW NAME: Marisa Siebel, MD
Year: 2003 – 2006
Internal Medicine Residency: Maimonides Medical Center, Brooklyn, NY
Board certifications: Internal Medicine; Hematology; Medical Oncology
Current position: Assistant Professor, State University of New York at Stony Brook, NY
Practice or research interests: Medical Oncology; Gastrointestinal oncology
FELLOW NAME: Julian Sprague, MD, PhD
Year: 2004 – 2007
Internal Medicine Residency: University of Vermont/Fletcher Allen Health Care
Board certifications: Internal Medicine
Current position: Assistant Professor of Medicine and Attending Physician, Hematology-Oncology Unit, University of Vermont College of Medicine/Fletcher Allen Health Care, VT
Practice or research interests: Hematologic malignancies
FELLOW NAME: Sabrina Witherby, MD
Year: 2004 – 2007
Internal Medicine Residency: Brown University, RI
Board certifications: Internal Medicine
Current position: Clinician educator at Memorial Hospital of Pawtucket, Brown University, RI
Practice or research interests: Geriatric oncology; Breast cancer; Ethics
FELLOW NAME: Regan Holdridge, MD
Year: 2005 – 2008
Internal Medicine Residency: University of Vermont/Fletcher Allen Health Care
Board certifications: Internal Medicine
Current position: 3rd year fellow
Practice or research interests: Breast oncology; clinical practice
FELLOW NAME: Kim Dittus, MD, PhD
Year: 2005 – 2008
Internal Medicine Residency: East Tennessee State University, TN
Board certifications: Internal Medicine
Current position: 3rd year fellow
Practice or research interests: Exercise and cancer; patient oriented research
FELLOW NAME: Steve Emmons, MD
Year: 2006 – 2009
Internal Medicine Residency: Arizona Health Sciences Center, Tucson, AZ
Board certifications: Internal Medicine
Current position: 2nd year fellow
Practice or research interests: Cancer genetics (tentative)
FELLOW NAME: Todd Whitman, MD
Year: 2006 – 2009
Internal Medicine Residency: University of Vermont/Fletcher Allen Health Care, VT
Board certifications: Internal Medicine
Current position: 2nd year fellow
Practice or research interests: Breast cancer (tentative)
FELLOW NAME: Farrah Khan, MD
Year: 2007 – 2010
Internal Medicine Residency: St. Elizabeth Medical Center, Boston, MA
Board certifications: Internal Medicine
Current position: 1st year fellow
Practice or research interests:
FELLOW NAME: Madhuri Vithala, MD
Year: 2007 – 2010
Internal Medicine Residency: University of Connecticut Health Center, Farmington, CT
Board certifications: Internal Medicine
Current position: 1st year fellow
Practice or research interests:
Back to the top
Fellow’s Research Projects and Publications
Projects
Quality of Life in Premenopsausal Women with Metastatic Breast Cancer Treated with a GnRH Agonist and an Aromatase Inhibitor” – Marisa Siebel, M.D., Susan Burdette-Radoux, M.D.
Margaret Kennedy, MD. Hematology/Oncology Fellowship Research. Genetic Risk Factors for Venous Thrombosis in Cancer Patients. 2000-01. Funding, CALGB Foundation Clinical Research Award. 2001-03. NHLBI Hemostasis and Thrombosis Training Grant. Finalist, Jeremiah and Rose Stamler Research Award for New Investigators, American Heart Association Council on Epidemiology and Prevention, 2003.
Neil Zakai, MD. Internal Medicine Residency and Hematology-Oncology Fellowship Research. Anemia and the risk of mortality in the elderly. Efficacy of Deep Venous Thrombosis Prophylaxis in Medical Inpatients.
Current Position. Assistant Professor of Medicine, Hematology-Oncology Division, University of Vermont (7/2007).
Publications
Grunberg SM, Greenblatt M, Ospina D, Valentine J: Phase I/II Study of Paclitaxel/Vinorelbine for Advanced Non-Small Cell Lung Cancer. Lung Cancer 29 Suppl 1:56, 2000.
Andreescu ACM, Cushman M, Hammond JM, Wood ME: Trousseau’s syndrome treated with long-term subcutaneous lepirudin: case report and review of the literature. J Thromb Thrombolysis 11(1): 33-37, 2001.
Srivastava A, McKinnon W, Wood ME: Risk of breast and ovarian cancer in women with strong family histories. Oncology (Huntingt). 15(7):889-902, 2001.
Grunberg SM, Srivastava A, Grunberg KJ, Weeks J: Intensity of Chemotherapy-Induced Emesis and Overall Survival as Determinants of a Global Utility Score. Support Care Cancer 10:624-629, 2002.
Holmes C, Muss HB: Diagnosis and Treatment of Breast Cancer in the Elderly. CA Cancer J Clin 53:227-244, 2003.
Eneman JD, Wood ME, Muss HB: Selecting Adjuvant Endocrine Therapy for Breast Cancer. Oncology 18(14):1733-1744, 2004.
Eneman JD, Wood ME, Muss HB: Selecting Adjuvant Endocrine Therapy for Breast Cancer. Oncology (Huntingt), 18(14):1733-44, 2004.
Zakai N, Wright J, Cushman M. Risk factors for venous thrombosis in medical inpatients: validation of a thrombosis risk score. J Thromb Haemost 2004;2:2156-61.
Siebel MF, Muss, HB: The Influence of Aging on the Early Detection, Diagnosis, and Treatment of Breast Cancer. Current Oncology Reports 7(1):23-30, 2005.
Kennedy M, Andreescu ACM, Greenblatt MS, Jiang H, Thomas CA, Chassereau L, Wong C, Durda P, Cushman M. Factor V Leiden, prothrombin 20210A and the risk of venous thrombosis among cancer patients. British J Haematol 2005;128:386-8.
Kennedy M, Solomon C, Manolio TA, Criqui MH, Newman AB, Polak JF, Burke GL, Enright P, Cushman M. Risk factors for worsening ankle-brachial index in men and women 65 years or older: the Cardiovascular Health Study. Arch Intern Med 2005;165:1896-1902.
Grunberg SM, Dugan MC, Greenblatt MS, Ospina DJ, Valentine JW: Phase I/II trial of Paclitaxel and Vinorelbine in advanced non-small cell lung cancer, Cancer Investigation 23:392-398 2005.
Witherby SM, Muss HB: Special Issues Related to Breast Cancer Adjuvant Therapy in Older Women. The Breast 14:600-611, 2005.
Witherby SM, Muss HB: Update in Medical Oncology for Older Patients: Focus on Breast Cancer: Management of Early Breast Cancer. Cancer J 11:506-17, 2005.
Eneman J, Philips G: Cancer Management and Chemotherapy Use in Patients with End-Stage Renal Disease. Oncology 19:1199-1212, 2005.
Zakai NA, Katz R, Hirsch C, Shlipak MG, Chaves P, Newman A, Cushman M. Prospective study of anemia status, hemoglobin and mortality in the elderly: the Cardiovascular Health Study. Arch Intern Med 2005;165:1-7.
Witherby SM: Muss HB: Managing Early Stage Breast Cancer in Your Older Patients. Oncology 20(9)1003-1012, 2006.
Sprague JR, Wood ME: Statins and breast cancer prevention: time for randomized controlled trials. J Clin Oncol. 24(13):2129-30, author reply 2130-1, 2006.
Sprague J, Wood M: Breast cancer prevention: time for randomized controlled trials with statins. Arch Intern Med 166(10):1143-4, 2006.
Grunberg S, Dugan M, Chassereau L, Fingar J, Rivers K, Burdette-Radoux S: Prevention of Moderately Emetogenic Chemotherapy-Induced Nausea and Vomiting with a 1-Day 3-Drug Antiemetic Regimen – Preliminary Report. Support Care Cancer 14:596, 2006
Dittus K, Muss HB: “Management of the Frail Elderly with Breast Cancer”. Oncology 21(14): 1727-1734, 2007.
Witherby SM, Butnor KJ, Grunberg SM: Malignant Mesothelioma Following Thoracic Radiotherapy for Lung Cancer. Lung Cancer 57:410-413, 2007.
Grunberg SM, Dugan M, Muss HB, Wood M, Burdette-Radoux SB, Weisberg T: Efficacy of a 1-Day 3-Drug Antiemetic Regimen for Prevention of Acute and Delayed Nausea and Vomiting Induced by Moderately Emetogenic Chemotherapy. J Clin Oncol 25:520s, 2007 (Suppl: Abstract 9111).
Zakai N, Jenny NS, Tracy RP, Reiner AP, Psaty BM, Schwartz S, Cushman M. Comparison of multiple inflammatory markers in the prediction of cardiovascular disease in older men and women. J Thromb Haemost 2007;5:1128-35.
Zakai NA, Ohira T, White R, Folsom AR, Cushman M. Prospective study of the activated partial thromboplastin time and risk of incident venous thromboembolism: the Longitudinal Investigation of Thromboembolism Etiology. In Press (2008) Am J Med.
Suzuki T, Katz R, Jenny NS, LeWinter MM, Zakai NA, Barzilay JI, Cushman M. Metabolic syndrome, inflammation, and the incidence of congestive heart failure in the elderly: the Cardiovascular Health Study. Submitted.
Book Chapters
Srivastava A, Wood ME: Polycytnemic States. In: Hematology/Oncology Secrets, 3rd edition, Hanley & Belfus 2003.
Muss HB, Holmes CE: "Tailored System Therapy for the Elderly Woman". Breast Cancer Management and Molecular Medicine: Towards Tailored Approaches. (ed) Piccart M; Wood WC, -C Hung M, Solin LE, Cardoso F. Springer-Verlay Berlin – publishers (19:375-396, 2006).
Grunberg SM, Bibawi S: Lung Cancer. In: Hunter CP, Johnson KA, Muss HB (eds). Cancer in the Elderly, New York, Marcel Dekker, 2000, pp 345-360.
Spielvogle WE, Grunberg S: Primary Brain Tumors. In: Wood ME, Philips GK (eds). Hematology/Oncology Secrets - 3rd Edition, Philadelphia, Hanley & Belfus, 2003, pp 358-361.
Grunberg SM, Dugan M: Integrated Therapy of Nausea and Vomiting. In: Hesketh P (ed.) Management of Nausea and Vomiting in Cancer and Cancer Treatment, Sudbury, MA, Jones and Bartlett Publishers, 2005, pp 147-160.
Grunberg SM, Dugan M, Gralla RJ: Management of Nausea and Vomiting. In: Pazdur R, Coia LR, Hoskins WJ, Wagman LD (eds). Cancer Management: A Multidisciplinary Approach – 9th Edition, New York, CMP Healthcare Media, 2005, pp 875-886.
Witherby S, Grunberg SM: Lung Cancer. In: Muss HB, Hunter CP, Johnson KA (eds).Treatment and Management of Cancer in the Elderly, New York, Taylor & Francis, 2006, pp 225-248.
Grunberg SM, Siebel M: Management of Nausea and Vomiting. In: Pazdur R, Coia LR, Hoskins WJ, Wagman LD (eds). Cancer Management: A Multidisciplinary Approach – 10th Edition, Darien, CT, CMP Healthcare Media, 2007, pp 873-884.
Abstracts
Ospina DJ, Unger P, Grunberg SM: Value of Extended Staging in Clinical Stage I Non-Small Cell Lung Cancer. Proc ASCO 17:426A, 1998.
Bibawi S, Chassereau L, Wood M, Muss H, Cooper M: A Phase I Study of Docetaxel and Mitoxantrone Combination Chemotherapy in Patients with Advanced Solid Tumors. Proc ASCO 18:783, 1999.
Srivastava A, Grunberg KJ, Weeks JC, Grunberg SM: Effect of Emesis Intensity and Expected Survival on Utility Scores for Chemotherapy-Induced Nausea and Vomiting. Proc ASCO 18:421A, 1999.
Grunberg SM, Greenblatt M, Ospina D, Valentine J: Phase I Study of Paclitaxel/Vinorelbine for Advanced Non-Small Cell Lung Cancer. Proc ASCO 18:507A, 1999.
Sprague JR, McKinnon WC, Wood ME: Comparison of Questionnaire and counseling family history information. Am J Hum Genet 74(4, suppl) Abstr # 1406, 2004.
Witherby SM, Johnson JV, O’Brien P, Demers LM, Mount SL, Muss HB: Efficacy and Safety of Vaginal Testosterone for Atrophic Vaginitis in Breast Cancer Patients on Aromatase Inhibitors: A Pilot Study. Breast Cancer Research & Treatment 106(Suppl 1), Abstr #6068, S276, 2007.
Grunberg, SM, Dugan M, Muss HB, Wood M, Burdette-Radoux S, Weisberg T. Efficacy of a 1-day 3-drug antiemetic regimen for prevention of acute and delayed nausea and vomiting induced by moderately emetogenic chemotherapy. Journal of Clinical Oncology, 2007 ASCO Annual Meeting Proceedings Part I. 25 (Suppl 18S), Abstr # 9111, 2007.
In Press
Casey TM, Eneman J, Crocker A, Tessitore J, Stanley M, Harlow S, Bunn JY, Weaver D, Muss H, Plaut K. “Cancer Associated Fibroblasts Stimulated by Transforming Growth Factor Beta1 (TGF-?1) Increase Invasion Rate of Tumor Cells: A Population Study.” (In Press) Breast Cancer Research & Treatment, 2007.
Back to the top
|
|
|
